Boryung Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boryung Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Chongkundang Holdings Corp
sales of 335.68 billion Korean Won [US$296.74 million]
of which 97%
JW Pharmaceutical Corp
(467.47 billion Korean Won [US$413.24 million]
(396.13 billion Korean Won [US$350.18 million]
During the year ended December of 2016, sales at
Boryung Pharmaceutical Company Limited were 409.14 billion Korean Won (US$361.68 million).
a very small
increase of 1.9%
versus 2015, when the company's sales were 401.35 billion Korean Won.
This was the fifth consecutive year of sales increases at Boryung Pharmaceutical Company Limited
(and since 2011, sales have increased a total of 33%).